- Home
- FOR vs AMLX Comparison
FOR vs AMLX Comparison
Compare FOR & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOR
- AMLX
- Stock Information
- Founded
- FOR 2005
- AMLX 2014
- Country
- FOR United States
- AMLX United States
- Employees
- FOR N/A
- AMLX N/A
- Industry
- FOR Real Estate
- AMLX Biotechnology: Pharmaceutical Preparations
- Sector
- FOR Finance
- AMLX Health Care
- Exchange
- FOR Nasdaq
- AMLX Nasdaq
- Market Cap
- FOR 1.2B
- AMLX 1.3B
- IPO Year
- FOR 2007
- AMLX 2022
- Fundamental
- Price
- FOR $24.54
- AMLX $14.79
- Analyst Decision
- FOR Strong Buy
- AMLX Strong Buy
- Analyst Count
- FOR 4
- AMLX 7
- Target Price
- FOR $31.25
- AMLX $17.43
- AVG Volume (30 Days)
- FOR 128.6K
- AMLX 1.5M
- Earning Date
- FOR 10-28-2025
- AMLX 11-06-2025
- Dividend Yield
- FOR N/A
- AMLX N/A
- EPS Growth
- FOR N/A
- AMLX N/A
- EPS
- FOR 3.29
- AMLX N/A
- Revenue
- FOR $1,662,400,000.00
- AMLX N/A
- Revenue This Year
- FOR $1.24
- AMLX N/A
- Revenue Next Year
- FOR $8.97
- AMLX N/A
- P/E Ratio
- FOR $7.47
- AMLX N/A
- Revenue Growth
- FOR 10.14
- AMLX N/A
- 52 Week Low
- FOR $18.00
- AMLX $2.60
- 52 Week High
- FOR $31.19
- AMLX $16.96
- Technical
- Relative Strength Index (RSI)
- FOR 47.78
- AMLX 60.27
- Support Level
- FOR $22.81
- AMLX $11.93
- Resistance Level
- FOR $25.34
- AMLX $15.09
- Average True Range (ATR)
- FOR 0.79
- AMLX 1.00
- MACD
- FOR -0.07
- AMLX 0.14
- Stochastic Oscillator
- FOR 66.79
- AMLX 89.70
About FOR Forestar Group Inc
Forestar Group Inc is a residential lot development company with operations across the United States. The core business segment for the company is real estate which generates all of it's revenues. The firm fundamentally acquires entitled real estate and develops it into finished residential lots for sale to homebuilders with a strategic focus on asset turns and efficiency. Single-family residential communities account for the majority of their real estate projects. The company utilizes a lower-risk business model mainly by investing in short duration, phased development projects.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.